NCT06885385 2025-06-24
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Recruiting
Clinical Trials
3 trialsNCT05364489 2022-05-20
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2 Not yet recruiting
NCT03126071 2021-08-30
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown